Leucine
1 organisation holds 1 active FDA Type IV Drug Master File for Leucine. 12 valid EDQM Certificates of Suitability are on record for the same substance.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity); EDQM Certification Online Database. Methodology
Active Type IV DMFs (1)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| CAMBRIDGE ISOTOPE LABORATORIES INC United States | 21618 | L-LEUCINE (U-13C6) | May 2008 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
Valid CEPs for this substance (12)
| Holder | Country | Certificate | Issued |
|---|---|---|---|
| EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CN | CN | CEP 2025-632 - Rev 01 Leucine, Process 2 | Oct 2026 |
| AJINOMOTO CO INC | JP | CEP 2008-233 - Rev 02 Leucine | Aug 2026 |
| AJINOMOTO CO INC | JP | CEP 2012-052 - Rev 02 Leucine | Aug 2026 |
| EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CN | CN | CEP 2025-632 - Rev 00 Leucine, Process 2 | Jun 2026 |
| SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai CN | CN | CEP 2010-189 - Rev 01 Leucine | Oct 2025 |
| YICHANG SANXIA PROUDIN BIOPHARMACEUTICAL CO., LTD. Yichang CN | CN | CEP 2023-459 - Rev 00 Leucine | Jun 2024 |
| EVONIK REXIM (NANNING) PHARMACEUTICAL CO., LTD. Nanning CN | CN | CEP 2008-097 - Rev 02 Leucine | Nov 2023 |
| TIANJIN TIANYAO PHARMACEUTICALS CO LTD | CN | R0-CEP 2020-207 - Rev 00 Leucine | Oct 2022 |
| AMINO GMBH | DE | R1-CEP 2014-156 - Rev 00 Leucine, Obtained from fermentation | Dec 2021 |
| AMINO GMBH | DE | R1-CEP 2014-088 - Rev 00 Leucine, From feathers | Dec 2019 |
| AMINO GMBH | DE | R1-CEP 1997-011 - Rev 04 Leucine | Nov 2013 |
| Kyowa Hakko Bio Co., Ltd. | JP | R1-CEP 1999-160 - Rev 03 Leucine | Aug 2013 |
Certification Online Database, European Directorate for the Quality of Medicines & HealthCare. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Leucine.
Do you supply Leucine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.